Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Post Traumatic Stress Disorder
Biotech
Jazz drops PTSD drug over phase 2 trial failure
Jazz is planning to drop its post-traumatic stress disorder therapy after the fatty acid amide hydrolase inhibitor failed to beat placebo
James Waldron
Dec 22, 2023 5:21am
FDA clears 1st neuromodulation device for PTSD treatment
Mar 24, 2023 10:50am
Study: Sleep wearable could reduce PTSD risk
Aug 17, 2016 10:28am